We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Indivior Plc | LSE:INDV | London | Ordinary Share | GB00BN4HT335 | ORD USD0.50 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
8.00 | 0.57% | 1,408.00 | 1,403.00 | 1,414.00 | 1,426.00 | 1,365.00 | 1,400.00 | 602,828 | 16:35:05 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.09B | 2M | 0.0148 | 952.03 | 1.91B |
Date | Subject | Author | Discuss |
---|---|---|---|
03/6/2016 16:28 | in auction cant buy | falia | |
03/6/2016 16:19 | dont miss out rns | falia | |
03/6/2016 15:52 | Leak of FDA fastrack? | bad robot | |
03/6/2016 15:45 | looks like a bid or fda approval leak | falia | |
03/6/2016 15:37 | where is everyone the share price is up by32pc? no news | ali47fish | |
27/5/2016 08:54 | It's good news but fast tracking isn't that unusual.How those phase 3 trials go is what it's all about and whether the FDA approval is ultimately received.That said,I thought the shares might tick up on this announcement. | steeplejack | |
26/5/2016 19:08 | fda approval to fastrack adrug no comments from anyoneas to how significant this is - i'am asking | ali47fish | |
25/5/2016 14:34 | I see a few technical presentations are taking place in the US so I guess it's reinforcing the Company's standing for it's technical competence plus commitment to the addiction sector. Cannot get my head around anything more than that! | gregmorg | |
12/5/2016 13:58 | I didn't bother attending the AGM today as its location somewhere near Heathrow on the Bath Road said it all! Obviously the location was chosen to fit in with the executives busy travel schedules and with every expectation that no shareholders or even representative from institutional investors were likely to turn up. These locations get chosen to highlight the point that nothing of interest is likely to be said and its all just a matter of regulatory form. Still the share price has recovered a tad from its wobbles although I guess we wait till some Court judgements or other drug news. | gregmorg | |
05/5/2016 09:59 | Thanks Greg.Yes,I feel much happier having listened to Jamie conversing with the management.Looks like there's no generic film competitor immediately in the wings and a year out you'll have the once a month injectable,a potentially superior product.So,I'll stick with it. | steeplejack | |
04/5/2016 10:18 | Finally listened to the webcast following the 1st Qtr. I didn't learn much more than having read the statement . Until the question and answer session and the 29th minute. Steeplejack that part was well worth listening to! The insight for me was provided by the extremely persistent, maybe American who probably worked for an American Investment House. This tenacious lady provided me with a very good reason to be patient. All about Bup Depot Monthly. She knew her stuff although the management couldn't provide her with percentage probabilities in their replies. The CEO referred to her as Jamie but, as she didn't introduce herself on this particular question, she maybe had asked an earlier question or was well known to them. | gregmorg | |
03/5/2016 14:22 | I didn't click into the presentation because of other commitments. Did anyone glean anything from it? | gregmorg | |
03/5/2016 12:19 | Hell of a gap between what the company feels are OK figures and what the market appears to expect.Being a shareholder here is an uncomfortable ride. | steeplejack | |
03/5/2016 10:52 | "The humidifier sterilisers were sold from 2001 to 2011, and South Korea is believed to be the only country where they were available.Last month, Reckitt Benckiser also apologised in a written statement for not communicating quickly enough with the families affected."I don't think that Individor was spun off with humidifier sterilisers amongst its drug portfolio.Nonetheles | steeplejack | |
03/5/2016 10:45 | forgive my ignorance, I am not up to speed on what was spun off from RB. | tonysss13 | |
03/5/2016 10:39 | Um,yes that's probably good enough to have some marketmakers kick the stock but I don't think it'll have anything to do with Individor,it's a Reckitt problem . | steeplejack | |
03/5/2016 10:32 | to do with this maybe hxxp://news.sky.com/ | tonysss13 | |
03/5/2016 10:12 | when is the update i pencilled in today - but nothing has apearted? | ali47fish | |
03/5/2016 09:57 | Mm, could they be they teeing up a few punters for an acquisition? | gregmorg | |
03/5/2016 09:24 | Down 6% on opening and we don't get the figures til 1pm!Not encouraging.Can we assume someone's steamed open the envelope. | steeplejack | |
28/4/2016 18:33 | Agreed although does a Phase 1 failure really require an announcement? I am not that keen on the other part of the announcement although apparently now rectified. Waiting patiently for some good news but I guess more time needed. | gregmorg | |
28/4/2016 14:31 | No big deal, a drug failing in phase 1 | steeplejack |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions